4 Diffuse Large B-Cell Lymphoma Clinical Trials in Gilbert, AZ (2026)

Q: How do I join a clinical trial in Gilbert?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Gilbert research site will contact you.

Recruiting Diffuse Large B-Cell Lymphoma Studies in Gilbert

NCT06717347Recruiting

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

The purpose of this study is to evaluate if zilovertamab vedotin with standard treatment can help people live longer without the cancer growing or spreading than people who receive standard treatment ...

Gilbert, AZPHASE31,046 participantsMerck Sharp & Dohme LLC

View Study Details

NCT07188558Recruiting

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

This Phase 3 study compares rondecabtagene autoleucel (ronde-cel), a dual-targeting CD19/CD20 CAR T-cell therapy, with investigator's choice of CD19 CAR T-cell therapy in patients with relapsed or ref...

Gilbert, AZPHASE3400 participantsLyell Immunopharma, Inc.

View Study Details

NCT04792489Recruiting

DALY II USA/ MB-CART2019.1 for DLBCL

DALY II USA is a phase II, multi-center, single arm study to evaluate the efficacy, safety, and pharmacokinetics of zamtocabtagene autoleucel (MB-CART2019.1) in patients with relapsed and/or refractor...

Gilbert, AZPHASE2315 participantsMiltenyi Biomedicine GmbH

View Study Details

NCT06500273Recruiting

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

This is a randomized, open-label study in adult patients who have completed standard first line therapy for large B-cell lymphoma (LBCL) and achieved a complete response or partial response suitable f...

Gilbert, AZPHASE2250 participantsAllogene Therapeutics

View Study Details

About Diffuse Large B-Cell Lymphoma Clinical Trials in Gilbert

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma, accounting for about 30% of cases. It is an aggressive lymphoma that grows rapidly. Treatment usually involves chemoimmunotherapy, with CAR-T cell therapy for relapsed cases.

There are currently 4 diffuse large b-cell lymphoma clinical trials recruiting participants in Gilbert, AZ. These studies are seeking a combined 2,011 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Lyell Immunopharma, Inc., Miltenyi Biomedicine GmbH and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Diffuse Large B-Cell Lymphoma Clinical Trials in Gilbert — FAQ

Are there diffuse large b-cell lymphoma clinical trials in Gilbert?

Yes, there are 4 diffuse large b-cell lymphoma clinical trials currently recruiting in Gilbert, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Gilbert?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Gilbert research site will contact you about next steps.

Are clinical trials in Gilbert free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Gilbert studies also compensate for your time and travel.

What diffuse large b-cell lymphoma treatments are being tested?

The 4 active trials in Gilbert are testing new therapies including novel drugs, biologics, and treatment approaches for diffuse large b-cell lymphoma.

Data updated October 16, 2026 from ClinicalTrials.gov